Canton Biologics is a biotechnology company specializing in research and development of protein products. Founded in 2015, Canton Biologics focuses on developing and manufacturing monoclonal antibodies, bispecific antibodies and other therapeutic recombinant proteins. The company’s headquarters are located in Guangzhou, China, with a holding subsidiary in Switzerland and a CMO and an R&D unit in Foshan, China. With a protein drug production line that meets the FDA, EMA and the Chinese cGMP standards, Canton Biologics is building the most efficient biopharmaceutical R&D and production platform in South China.

As Head of Cell Line Development, you will manage a group of people within the Department of Bioprocess Development to deliver high yield cell lines expressing biologics and develop innovative technologies.